Back to Targets, Assays & Screening
Novartis

Targets, Assays & Screening

This course focuses on the early stages of drug discovery and the identification of promising compounds with which to begin the hunt for a novel drug.  Different types of assays and methods are reviewed that are used to screen libraries of molecules in the preliminary search for compounds with activity.  Methods are discussed for validating that active molecules are indeed engaging a target associated with a predicted therapeutic benefit. Target audience: This course is suitable for life scientists, clinicians, and individuals from fields that support drug discovery (e.g., patents, finance, licensing, etc.) interested in learning more about the pharmaceutical/biotechnology sector. Advanced undergraduate coursework or practical familiarity/working knowledge in biological sciences and organic chemistry is recommended.

Status: Drug Development
Status: Pharmacology
IntermediateCourse9 hours

Featured reviews

AD

5.0Reviewed Jun 22, 2025

Great course. Clear explanations and very easy to digest materials. Thanks to the entire team

FT

5.0Reviewed Jun 24, 2025

this course is very well designed. it really cleared my concepts and equipped me with sufficient knowledge and guide about target and assays

All reviews

Showing: 5 of 5

Katarína Kukanová
5.0
Reviewed May 19, 2024
Fatima Tariq
5.0
Reviewed Jun 25, 2025
Amagyei-Antwi David
5.0
Reviewed Jun 23, 2025
SADEEM AHMAD ALI ALWEHIBI
5.0
Reviewed Jan 14, 2026
Mobasser Hosain
5.0
Reviewed Feb 17, 2025